Even so, Glenn Micalizio, a chemist at Scripps, and his colleagues didn't grow to be considering the compound because of its pharmaceutical opportunity. Fairly, they understood that its advanced carbon skeleton was an ideal focus on for tests a sort of response they experienced just lately d